medline.ch Dermatologie Psoriasis

	Tildrakizumab Improves Disease Severity and Patient-Reported Outcomes in Moderate-to-Severe Chronic Plaque Psoriasis: A Prospective Real-World Study. Dermatol Ther (Heidelb) Facheris P, Piscazzi F, Fiorillo G, Valenti M, Costanzo A, Borroni RG. PMID: 42029886 [PubMed - as supplied by publisher]
	3D-Printed lesion-conformal light-guiding patches for precise and personalized psoriasis phototherapy. Biomater Sci Wang Y, Mei L, Wan T, Fu Y, Xue X, Guo W, Wang Y, Zhao Y, Liu R. PMID: 42029092 [PubMed - as supplied by publisher]
	Prevalence and risk factors of fatty liver disease in psoriasis: A systematic review and meta-analysis based on NAFLD/MAFLD diagnostic criteria. JAAD Int Shen J, Liu L, Wang J, Cai X, Zhang M, Wang Q, Li X, Sun X. PMID: 42027986 [PubMed]
	A Study on Early Screening and Disease Characteristics of Psoriatic Arthritis Based on PEST Questionnaire and Musculoskeletal Ultrasound. J Inflamm Res Wei J, Guo Y, Ma J, Luo S, Li Y, Zhou Q, Tong X, Wang Z, Wang H. PMID: 42027255 [PubMed]
	Diagnosis and therapeutic management of psoriatic arthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA). Ther Adv Musculoskelet Dis Ramírez J, López-Medina C, Montilla C, Moreno M, Moreno MJ, Navarro V, Díaz D, Fernández-Clotet A, Riera-Monroig J, Díaz-Del Campo P, Cañete JD, Queiro R. PMID: 42027204 [PubMed]
	Predictors of early high-level response to bimekizumab in patients with moderate-to-severe plaque psoriasis: a real-world cohort study. An Bras Dermatol Engin B, Demir Y, Yildirim G, Diken FZ, Yildiz B, Kutlubay Z, Serdaroglu S. PMID: 42025118 [PubMed - as supplied by publisher]
	Subclinical Enthesitis in Psoriasis Patients as Predictors of Arthritis: The EPESCA Study. J Psoriasis Psoriatic Arthritis Di Donato E, Becciolini A, Di Nuzzo S, Chernyschova N, Commisso C, Lamorte S, Fantini C, Satolli F, Santilli D, Lucchini G, Feliciani C, Sverzellati N, Ariani A. PMID: 42021782 [PubMed - as supplied by publisher]
	Comparing the efficacy and safety of biosimilar BAT2506 with reference golimumab in patients with active psoriatic arthritis: 24-week results of a phase 3, multicenter, double-blind, randomized, parallel-group study. Expert Opin Biol Ther Tang H, Dokoupilova E, Batko B, Zawadzki M, Batalov A, Liu Y, Yang X, Zhou Y, Dong Q, Liu Y. PMID: 42021476 [PubMed - as supplied by publisher]
	Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: A target trial emulation using the Italian VALORE distributed database network. Pharmacol Res Spini A, L'Abbate L, Ingrasciotta Y, Carollo M, Bellitto C, Leoni O, Zanforlini M, Ancona D, Stella P, Cavazzana A, Scapin A, Lopes S, Belleudi V, Ledda S, Carta P, Rossi P, Ejlli L, Sapigni E, Puccini A, Scarpelli RF, De Sarro G, Allotta A, Addario Pollina S, Da Cas R, Bucaneve G, Mangano AMP, Balducci F, Sorrentino C, Senesi I, Tuccori M, Gini R, Trama U, Bernardi FF, Mayer F, Alegiani SS, Massari M, Guarneri C, Gisondi P, Fontana A, Patorno E, Trifirò G. PMID: 42019563 [PubMed - as supplied by publisher]
	Genetic Evidence Linking Immune Cell Subsets to Psoriatic Arthritis Susceptibility: A Mendelian Randomization Study. Psoriasis (Auckl) Wang H, Ma M, Wang C, Zhen Y, Li S. PMID: 42016305 [PubMed]
	Role of the STAT3 Signaling Pathway in Cell Proliferation and Inflammation in Psoriasis and Approaches for Targeted Therapies: A Review. Med Sci Monit Li L, Chen L, Zhang C, Yao W, Li Z, Tian F. PMID: 42015469 [PubMed - indexed for MEDLINE]
	International consensus on dose reduction of biologics for patients with psoriasis: The DR. Delphi study. J Eur Acad Dermatol Venereol van Riel CAM, Boehncke WH, Lambert JLW, Spuls PI, van der Schoot LS, van Ee I, de Jong EMGJ, van den Reek JMPA, eDelphi consortium. PMID: 42012299 [PubMed - as supplied by publisher]
	Nanodelivery of Gentiopicroside for Inflammatory Skin Lesions: Insights from Psoriasis and Diabetic Foot Ulcers. Int J Nanomedicine Wang W, Du L, Ye H, Liu W, Sun L, Wang H. PMID: 42011195 [PubMed - indexed for MEDLINE]
	An Exploratory Study to Identify Factors Associated with Recurrence of Generalized Pustular Psoriasis Flares in Adult Patients in Japan. Acta Derm Venereol Morita A, Okubo Y, Okuyama R, Mizutani Y, Kanazawa N, Otsuka A, Miyagi T, Shionoya M, Mizuno R, Saitoh M, Imafuku S. PMID: 42007809 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Adalimumab as Monotherapy Versus Adalimumab With Methotrexate for Psoriasis: A Systematic Review. Cureus Alanazi AF, Almahdi MA, Alqurashi SO, Alassaf S, Almohanna A, Alayed ST, Alshehri M, Alsubaie KS, Hakami S. PMID: 42005271 [PubMed]
	Spesolimab for generalized pustular psoriasis: A prospective study with a 6-month-follow-up. Clin Exp Dermatol Bahloul E, Turki K, Nouri M, Sellami K, Hammami H, Chaabouni R, Boudaya S, Tabka M, Marrakchi S, Bougacha N, Mokni M, Denguezli M, Turki H. PMID: 41999186 [PubMed - as supplied by publisher]
	Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study. Int J Dermatol Kögel J, Schuh S, Welzel J, Sticherling M, Sollfrank L, Berking C, Pumnea T, Glatzel V, French L, Lauffer F, Vitus MV, Biedermann T, Bauer S, Spindler M, Berneburg M, Niebel D. PMID: 41999064 [PubMed - as supplied by publisher]
	Molecular Biomarkers for Predicting Treatment Response in Psoriatic Arthritis. Rheum Dis Clin North Am Ribeiro AL, Barton A, Schwenk JM, Bertheussen H, de Wit M, Goodyear C, Siebert S, Pennington SR, FitzGerald O. PMID: 41997622 [PubMed - indexed for MEDLINE]
	Predictors of clinical response to biologics in psoriasis: A systematic review and meta-analysis. J Eur Acad Dermatol Venereol Mao X, Meng S, Wu P, Cao L, Wang L. PMID: 41995334 [PubMed - as supplied by publisher]
	Efficacy of Risankizumab in Moderate to Severe Psoriasis Considering Body Mass Index: A Scoping Review. Cureus Sarmiento K, Siqueiros M, Hernández M, Morales G, Orozco V, Pumarejo LF, Gonzalez AD. PMID: 41994714 [PubMed]

Artikel 1 - 20 / 27798

Seite 1 von 1390

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung